Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis

Date

2019

Author

Sharmin, S.
Lefort, M.
Andersen, J.
Horakova, D.
Havrdova, E. K.
Alroughani, R.
Lechner-Scott, J.

Metadata

Show full item record

Abstract

…

Source

Multiple Sclerosis Journal

Volume

25

URI

https://hdl.handle.net/20.500.12712/10631

Collections